Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
2.645
+0.195 (7.96%)
Aug 11, 2025, 12:51 PM - Market open
Veren Market Cap
Jasper Therapeutics has a market cap or net worth of $39.73 million as of August 11, 2025. Its market cap has decreased by -87.31% in one year.
Market Cap
39.73M
Enterprise Value
-9.40M
1-Year Change
-87.31%
Ranking
Category
Stock Price
2.65
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $39.73M, a decrease of -67.63%. That is a compound annual growth rate of -18.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 36.80M | -88.52% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |